🔗 Share this article Users Coming Off Slimming Injections Regain Weight at a Quadrupled Rate Compared to Dieters Obesity treatment often requires ongoing approaches. Fresh analysis reveals that people who discontinue popular slimming jabs like semaglutide or tirzepatide can put back on shed pounds far faster than those who stop traditional diet and exercise programs. Research printed in a major health publication demonstrates that while overweight people frequently drop substantial amounts of their total mass while on the medication, the mass returns at an average rate of 0.8 kg per month once they quit. "People using these treatments must be informed of the danger of rapid rebound weight gain when the medication is stopped," stated expert Dr. Susan Jebb. This pace of regain implies a return to starting weight within about a year and a half. Analyzing Approaches The research, which looked at dozens of studies involving over 9,000 of patients, contrasted the results of the injectable medications with older methods. Scientists emphasize that individuals who lose weight through diet and exercise typically experience a more gradual weight regain—around 100 grams monthly—once they finish. The Reason for the Fast Rebound Doctors believe the way of the drugs explains the heightened weight return. GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger. "Long-term administration of the hormone concentrations far above than the body's typical production could lead to the body to produce less of its own natural GLP-1, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a dietetics researcher. "Discontinuation of this hormone supplement results in hunger is uncontrolled, making overeating a significant risk." An Ongoing Disease? Medical guidelines advise the injections for people with obesity-related health risks, accompanied by recommended diet and exercise modifications. A number of clinicians argue that, due to the likelihood of relapse, the treatment might need to be life-long. This view is supported by pharmaceutical companies, who note that the results "underscore the chronic character of obesity," comparing it to managing conditions like hypertension. Patient Testimonies Individuals who have come off the medication describe a powerful return of hunger. "I experienced a trigger that goes on and I was suddenly ravenous," said an individual. The struggle is compounded if users have not developed lasting lifestyle or habit changes during therapy. Significant Use Survey data show that millions of people in the UK have tried these injections in the past year, with interest remaining high. Adoption is more common among women than men. The 40s and 50s age group shows the greatest usage rates. Many access the drugs through private prescriptions rather than the NHS. Finally, clinicians stress that while the jabs are powerful tools for shedding pounds, they are not a standalone fix and maintained weight loss relies on ongoing behavioural management.
Obesity treatment often requires ongoing approaches. Fresh analysis reveals that people who discontinue popular slimming jabs like semaglutide or tirzepatide can put back on shed pounds far faster than those who stop traditional diet and exercise programs. Research printed in a major health publication demonstrates that while overweight people frequently drop substantial amounts of their total mass while on the medication, the mass returns at an average rate of 0.8 kg per month once they quit. "People using these treatments must be informed of the danger of rapid rebound weight gain when the medication is stopped," stated expert Dr. Susan Jebb. This pace of regain implies a return to starting weight within about a year and a half. Analyzing Approaches The research, which looked at dozens of studies involving over 9,000 of patients, contrasted the results of the injectable medications with older methods. Scientists emphasize that individuals who lose weight through diet and exercise typically experience a more gradual weight regain—around 100 grams monthly—once they finish. The Reason for the Fast Rebound Doctors believe the way of the drugs explains the heightened weight return. GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger. "Long-term administration of the hormone concentrations far above than the body's typical production could lead to the body to produce less of its own natural GLP-1, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a dietetics researcher. "Discontinuation of this hormone supplement results in hunger is uncontrolled, making overeating a significant risk." An Ongoing Disease? Medical guidelines advise the injections for people with obesity-related health risks, accompanied by recommended diet and exercise modifications. A number of clinicians argue that, due to the likelihood of relapse, the treatment might need to be life-long. This view is supported by pharmaceutical companies, who note that the results "underscore the chronic character of obesity," comparing it to managing conditions like hypertension. Patient Testimonies Individuals who have come off the medication describe a powerful return of hunger. "I experienced a trigger that goes on and I was suddenly ravenous," said an individual. The struggle is compounded if users have not developed lasting lifestyle or habit changes during therapy. Significant Use Survey data show that millions of people in the UK have tried these injections in the past year, with interest remaining high. Adoption is more common among women than men. The 40s and 50s age group shows the greatest usage rates. Many access the drugs through private prescriptions rather than the NHS. Finally, clinicians stress that while the jabs are powerful tools for shedding pounds, they are not a standalone fix and maintained weight loss relies on ongoing behavioural management.